Stocks in the Spotlight Tuesday

Onyx Pharma and Alon USA fell. Holly and PH Glatfelter rose.

Shares of the biopharmaceuticals company plunged 26% after Onyx said it and partner Bayer ended a study for Nexavar in lung cancer, citing lack of efficacy and increased mortality. The company also reported that losses narrowed in the fourth quarter from a year ago, but that news was overshadowed by the halted trial. Bear...